WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007019860) GDNF DERIVED PEPTIDES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/019860    International Application No.:    PCT/DK2006/000448
Publication Date: 22.02.2007 International Filing Date: 15.08.2006
Chapter 2 Demand Filed:    17.10.2007    
IPC:
C07K 7/00 (2006.01), C07K 14/47 (2006.01), A61K 38/18 (2006.01)
Applicants: Copenhagen University [DK/DK]; Techtrans Unit, Blegdamsvej 3, DK-2200 København N (DK) (For All Designated States Except US).
BOCK, Elisabeth [DK/DK]; (DK) (For US Only).
BEREZIN, Vladimir [UA/DK]; (DK) (For US Only)
Inventors: BOCK, Elisabeth; (DK).
BEREZIN, Vladimir; (DK)
Agent: HøIBERG A/S; Store Kongensgade 59A, DK-1264 Copenhagen K. (DK)
Priority Data:
PA 2005 01153 16.08.2005 DK
Title (EN) GDNF DERIVED PEPTIDES
(FR) PEPTIDES DERIVES DU FACTEUR GDNF
Abstract: front page image
(EN)The present invention relates to peptide fragments derived from the proteins belonging to the TGFbeta superfamily, pharmaceutical compositions comprising said peptide fragments and uses thereof for treatment of a disease or condition wherein the effects of stimulating neuronal cell differentiation, neuronal cell survival, stimulating neural plasticity associated with learning and memory and/or inhibiting inflammatory response are beneficial for treatment.
(FR)La présente invention pour sur des fragments de peptides dérivés des protéines appartenant à la superfamille TGF-bêta, sur des compositions pharmaceutiques renfermant ces fragments de peptides et sur des utilisations de ceux-ci dans le traitement d'une maladie ou d'un état, les effets de la stimulation de la différenciation des cellules neuronales, la survie des cellules neuronales, la stimulation de la plasticité neurale associée à l'apprentissage et à la mémoire et/ou l'inhibition de la réponse inflammatoire étant bénéfiques au traitement.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)